1639 related articles for article (PubMed ID: 28886379)
1. Putting p53 in Context.
Kastenhuber ER; Lowe SW
Cell; 2017 Sep; 170(6):1062-1078. PubMed ID: 28886379
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of mutant p53 stabilization in cancer.
Frum RA; Grossman SR
Subcell Biochem; 2014; 85():187-97. PubMed ID: 25201195
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.
Schlereth K; Heyl C; Krampitz AM; Mernberger M; Finkernagel F; Scharfe M; Jarek M; Leich E; Rosenwald A; Stiewe T
PLoS Genet; 2013; 9(8):e1003726. PubMed ID: 23966881
[TBL] [Abstract][Full Text] [Related]
4. In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models.
Kenzelmann Broz D; Attardi LD
Carcinogenesis; 2010 Aug; 31(8):1311-8. PubMed ID: 20097732
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor p53 and its gain-of-function mutants in cancer.
Liu J; Zhang C; Feng Z
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):170-9. PubMed ID: 24374774
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.
Hernández Borrero LJ; El-Deiry WS
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188556. PubMed ID: 33932560
[TBL] [Abstract][Full Text] [Related]
7. Understanding p53 functions through p53 antibodies.
Sabapathy K; Lane DP
J Mol Cell Biol; 2019 Apr; 11(4):317-329. PubMed ID: 30907951
[TBL] [Abstract][Full Text] [Related]
8. Friend or Foe: MicroRNAs in the p53 network.
Luo Z; Cui R; Tili E; Croce C
Cancer Lett; 2018 Apr; 419():96-102. PubMed ID: 29330109
[TBL] [Abstract][Full Text] [Related]
9. p53's Extended Reach: The Mutant p53 Secretome.
Pavlakis E; Stiewe T
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32075247
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53 partners in crime.
Kim MP; Lozano G
Cell Death Differ; 2018 Jan; 25(1):161-168. PubMed ID: 29099488
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex.
Carrà G; Crivellaro S; Taulli R; Guerrasio A; Saglio G; Morotti A
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916821
[No Abstract] [Full Text] [Related]
12. The tumor suppressor gene TP53: implications for cancer management and therapy.
Seemann S; Maurici D; Olivier M; Caron de Fromentel C; Hainaut P
Crit Rev Clin Lab Sci; 2004; 41(5-6):551-83. PubMed ID: 15603511
[TBL] [Abstract][Full Text] [Related]
13. The role of p53 in cancer drug resistance and targeted chemotherapy.
Hientz K; Mohr A; Bhakta-Guha D; Efferth T
Oncotarget; 2017 Jan; 8(5):8921-8946. PubMed ID: 27888811
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressive functions of p53.
Zilfou JT; Lowe SW
Cold Spring Harb Perspect Biol; 2009 Nov; 1(5):a001883. PubMed ID: 20066118
[TBL] [Abstract][Full Text] [Related]
15. Targeting mutant p53 for efficient cancer therapy.
Bykov VJN; Eriksson SE; Bianchi J; Wiman KG
Nat Rev Cancer; 2018 Feb; 18(2):89-102. PubMed ID: 29242642
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNAs: p53's secret weapon in the fight against cancer?
Dangelmaier E; Lazar SB; Lal A
PLoS Biol; 2019 Feb; 17(2):e3000143. PubMed ID: 30759134
[TBL] [Abstract][Full Text] [Related]
17. Interaction between the Cockayne syndrome B and p53 proteins: implications for aging.
Frontini M; Proietti-De-Santis L
Aging (Albany NY); 2012 Feb; 4(2):89-97. PubMed ID: 22383384
[TBL] [Abstract][Full Text] [Related]
18. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
19. Novel cancer therapy by reactivation of the p53 apoptosis pathway.
Bykov VJ; Wiman KG
Ann Med; 2003; 35(7):458-65. PubMed ID: 14649328
[TBL] [Abstract][Full Text] [Related]
20. Small molecule activators of the p53 response.
Ladds MJGW; Laín S
J Mol Cell Biol; 2019 Mar; 11(3):245-254. PubMed ID: 30689917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
